CLCM
BLUE

Crawford Lake Capital Management’s bluebird bio BLUE Stock Holding History

Crawford Lake Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-695
Closed -$945K – 72
2017
Q2 		$945K Buy
+695
New +$839K 0.21% 92

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Crawford Lake Capital Management's BLUE Position: Q3 2017 in Review

Crawford Lake Capital Management sold out of bluebird bio (BLUE) in Q3 2017, closing a stake of 695 shares — an estimated $945K sold.

Crawford Lake Capital Management first reported a position in BLUE in Q2 2017 and held it in 1 quarter. The position peaked at $945K in Q2 2017. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Crawford Lake Capital Management reported no remaining bluebird bio position as of Q3 2017 after selling out during the quarter.
  • Crawford Lake Capital Management sold 695 bluebird bio shares in Q3 2017, an estimated $945K.
  • Crawford Lake Capital Management first reported a position in bluebird bio in Q2 2017 and held it in 1 quarter.
  • Crawford Lake Capital Management's bluebird bio position peaked at $945K in Q2 2017.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Crawford Lake Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.